Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 19 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Enteric nervous system-derived IL-18 orchestrates mucosal barrier immunityJarret, A.; Jackson, R.; Duizer, C.; Healy, M.E.; Zhao, J.; Rone, J.M.; Bielecki, P.; Sefik, E.; Roulis, M.; Rice, T.; Sivanathan, K.N.; Zhou, T.; Solis, A.G.; Honcharova-Biletska, H.; Vélez, K.; Hartner, S.; Low, J.S.; Qu, R.; de Zoete, M.R.; Palm, N.W.; et al.
2019A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancerWarren, A.; Massie, C.; Watt, K.; Luko, K.; Orafidiya, F.; Selth, L.; Mohammed, H.; Chohan, B.; Menon, S.; Baridi, A.; Zhao, W.; Escriu, C.; Pungsrinont, T.; D Santos, C.; Yang, X.; Taylor, C.; Qureshi, A.; Zecchini, V.; Shaw, G.; Dehm, S.; et al.
2023Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in LeukemiaKan, W.L.; Dhagat, U.; Hercus, T.R.; Kaufmann, K.B.; Nero, T.L.; Zeng, A.G.X.; Toubia, J.; Barry, E.F.; Broughton, S.E.; Gomez, G.A.; Dottore, M.; Cheung Tung Shing, K.S.; Thomas, D.; Benard, B.; Simpson, K.J.; Schoof, E.; Goodall, G.J.; Begley, C.G.; Ekert, P.G.; Tvorogov, D.; et al.
2019Treatment of type 2 diabetes with the designer cytokine IC7FcFindeisen, M.; Allen, T.L.; Henstridge, D.C.; Kammoun, H.; Brandon, A.E.; Baggio, L.L.; Watt, K.I.; Pal, M.; Cron, L.; Estevez, E.; Yang, C.; Kowalski, G.M.; O'Reilly, L.; Egan, C.; Sun, E.; Thai, L.M.; Krippner, G.; Adams, T.E.; Lee, R.S.; Grötzinger, J.; et al.
2015Essential versus accessory aspects of cell death: recommendations of the NCCD 2015Galluzzi, L.; Bravo-San Pedro, J.; Vitale, I.; Aaronson, S.; Abrams, J.; Adam, D.; Alnemri, E.; Altucci, L.; Andrews, D.; Annicchiarico-Petruzzelli, M.; Baehrecke, E.; Bazan, N.; Bertrand, M.; Bianchi, K.; Blagosklonny, M.; Blomgren, K.; Borner, C.; Bredesen, D.; Brenner, C.; Campanella, M.; et al.
2016Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic targetAsim, M.; Massie, C.; Orafidiya, F.; Pértega-Gomes, N.; Warren, A.; Esmaeili, M.; Selth, L.; Zecchini, H.; Luko, K.; Qureshi, A.; Baridi, A.; Menon, S.; Madhu, B.; Escriu, C.; Lyons, S.; Vowler, S.; Zecchini, V.; Shaw, G.; Hessenkemper, W.; Russell, R.; et al.
2022Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36Fernando, S.; Salagaras, T.; Schwarz, N.; Sandeman, L.; Tan, J.T.M.; Xie, J.; Zareh, J.; Jensen, K.; Williamson, A.; Dimasi, C.; Chhay, P.; Toledo-Flores, D.; Long, A.; Manavis, J.; Worthington, M.; Fitridge, R.; Di Bartolo, B.A.; Bursill, C.A.; Nicholls, S.J.; Proud, C.G.; et al.
2021Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: guidance using optical window intravital FRET imagingFloerchinger, A.; Murphy, K.J.; Latham, S.L.; Warren, S.C.; McCulloch, A.T.; Lee, Y.-K.; Stoehr, J.; Mélénec, P.; Guaman, C.S.; Metcalf, X.L.; Lee, V.; Zaratzian, A.; Da Silva, A.; Tayao, M.; Rolo, S.; Phimmachanh, M.; Sultani, G.; McDonald, L.; Mason, S.M.; Ferrari, N.; et al.
2021Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesityCao, E.; Watt, M.J.; Nowell, C.J.; Quach, T.; Simpson, J.S.; De Melo Ferreira, V.; Agarwal, S.; Chu, H.; Srivastava, A.; Anderson, D.; Gracia, G.; Lam, A.; Segal, G.; Hong, J.; Hu, L.; Phang, K.L.; Escott, A.B.J.; Windsor, J.A.; Phillips, A.R.J.; Creek, D.J.; et al.
2013Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionThomas, D.; Powell, J.; Vergez, F.; Segal, D.; Nguyen, N.; Baker, A.; Teh, T.; Barry, E.; Sarry, J.; Lee, E.; Nero, T.; Jabbour, A.; Giovanna, P.; Green, B.; Manenti, S.; Glaser, S.; Parker, M.; Lopez, A.; Ekert, P.; Lock, R.; et al.